查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466573

3D 列印藥品市場：按技術、型態、應用和最終用戶分類 - 全球預測 2024-2030

3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

3D列印藥品市場規模預計2023年為2.9272億美元，2024年達到3.3122億美元，預計2030年將達到7.4429億美元，複合年成長率為14.26%。

3D列印藥品是指利用3D列印技術生產具有改良的藥物傳遞機制的藥品。藥品 3D 列印可實現藥品製造的個人化、精確性和成本效率。 3D 列印藥物的普及正在徹底改變製藥業，使設計所需形狀、尺寸、劑量和交付速度的藥物成為可能，為患者提供個人化的醫療保健。藥物發現和開發活動的增加以及對個人化醫療的關注增加了對藥物 3D 列印等先進藥物製造技術的需求。然而，3D列印技術的初始成本較高，這可能會對3D列印藥品的生產產生負面影響。此外，3D列印技術的技術進步有望提高藥物生產效率並擴大其在藥物開發中的應用。

主要市場統計
基準年[2023] 2.9272億美元
預測年份 [2024] 33122萬美元
預測年份 [2030] 74429萬美元
複合年成長率（%） 14.26%

技術直寫技術提供個人化且有效的劑量解決方案

3D 列印藥物中的直寫技術採用精確的薄膜沉積方法來製造結構和成分受控的藥物。這種方法可以定製藥物配方，從而實現個人化醫療和更有效的藥物輸送。熔融積層製造（FDM）作為一種廣泛使用的3D列印技術，也應用於製藥業，以開發3D列印藥物。噴墨列印技術已在製藥業中應用於3D列印藥物，為沉澱藥物材料提供了精確且受控的方法。粉末層列印技術在製藥業顯示出創建客製化和受控藥物傳輸系統的前景。使用光固化成形法技術 3D 列印藥物有望創建具有精確劑量的自訂控制釋放藥物。

型態：採用膠囊型3D列印藥物的可能性

3D 列印有潛力透過創建針對患者的特定劑量來最佳化治療計劃。膠囊可以 3D 列印出多個隔間，每個隔間包含不同的藥物或劑量，從而促進聯合治療。奈米級 3D 列印可以創建具有控釋特性的載藥奈米粒子，以最佳化藥物傳輸。 3D 列印可以將活性藥物成分封裝在奈米顆粒內，防止它們劣化並確保穩定性。 3D 列印錠劑可以根據每個患者的需求進行客製化，從而實現個人化的劑量和治療計劃。 3D 列印能夠製造具有複雜幾何形狀的錠劑，例如影響藥物釋放動力學的多孔結構和多層設計。

應用擴大在神經治療藥物製造的用途

3D 列印藥物將透過提供個人化解決方案（例如客製化對準器、假牙和牙冠）徹底改變牙科產業。客製化的藥物輸送系統能夠針對牙周病等疾病達到精確的藥物釋放。該技術提高了治療效果，同時最大限度地減少了副作用。對於人工植牙，3D 列印有助於創建充滿藥物的支架，從而加速癒合並降低感染疾病風險。在神經病學領域，3D 列印藥物對於神經系統疾病的客製化治療方法至關重要。針對患者的特定藥物配方可以實現精確劑量並改善癲癇和神經退化性疾病等疾病的治療結果。 3D 列印將透過製造患者專用藥物和植入來改變整形外科護理。在整形外科藥物傳輸中，3D 列印能夠開發適合患者需求的個人化劑型。此外，載藥 3D 列印植入可提供受控的局部藥物釋放，以增強癒合過程、對抗發炎並促進骨再生。

最終使用者：3D列印藥物在診所和醫院的滲透

在診所和醫院，醫療專業人員專注於提供個人化藥物，青睞根據特定患者需求量身定做的 3D 列印藥物。這些 3D 列印藥物之所以受到青睞，是因為它們提高了治療效果，並降低了傳統大量生產藥物常見的風險和副作用。該實驗室正在充分利用 3D 列印藥物的精確度和準確度。 3D列印藥物使研究人員能夠對藥物交互作用和藥物功效進行具體調查和嚴格研究。專注於個人化醫療的專科診所擴大使用 3D 列印藥物來滿足患者的獨特需求。個人化藥物治療可根據每位患者獨特的生理機能定製藥物治療，從而提高患者的依從性和治療效率。醫生辦公室、醫院和專科診所正在廣泛採用 3D 列印藥物來增強患者治療通訊協定，而實驗室則專注於幫助醫療創新和藥物測試的實際好處。

區域洞察

由於醫學研發的進步、製藥業的強勁以及主要 3D 列印藥品製造商的存在，美洲在 3D 列印藥品市場中佔據關鍵地位。技術進步的不斷進步和醫療基礎設施的加強正在進一步推動該地區的市場前景。由於老年人口的增加、個人化醫療的努力、支持性的政府法規以及政府和主要製造商的資助活動，歐洲正在觀察 3D 列印藥物的重要市場。在中東和非洲，對技術實施和醫療基礎設施加固的投資不斷增加，促進了市場成長。在快速都市化、醫療技術創新、醫療成本上升以及需要定製藥物治療的老年人口不斷增加等因素的推動下，亞太地區正在經歷3D列印藥品市場的新興階段，顯示出巨大的成長潛力。

FPNV定位矩陣

FPNV定位矩陣對於評估3D列印醫藥市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 3D 列印藥品市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.3D列印醫藥市場的市場規模和預測是多少？

2.在3D列印藥品市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.3D列印醫藥市場的技術趨勢和法規結構是什麼？

4.3D列印藥品市場主要廠商的市場佔有率是多少？

5.進入3D列印醫藥市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對速效藥物的需求迅速增加
      • 擴大個人化藥物的採用和複雜藥物的生產
      • 廣泛利用3D列印技術製造癌症治療藥物
    • 抑制因素
      • 與 3D 列印藥品製造相關的材料限制
    • 機會
      • 3D列印技術持續技術發展
      • 大量投資生產 3D 列印藥品
    • 任務
      • 3D 列印藥品製造的複雜性
  • 市場區隔分析
    • 技術：直寫技術提供個人化、有效的劑量解決方案
    • 型態：可採用膠囊形式的 3D 列印藥物
    • 應用：擴大在神經系統藥物製造的應用
    • 最終用戶：3D列印藥品在診所和醫院的滲透率較高
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第 6 章 3D 列印藥品市場：依技術分類

  • 直接寫入
  • 熔融沈積法
  • 噴墨印刷
  • 粉紅床印刷
  • 立體光刻技術
  • 拉鍊劑量

第7章依劑型型態的3D列印藥品市場

  • 膠囊
  • 奈米顆粒
  • 藥片

第8章 3D列印醫藥市場：依應用分類

  • 牙科
  • 神經病學
  • 整形外科

第 9 章 3D 列印製藥市場：依最終用戶分類

  • 診所和醫院
  • 研究室
  • 專科診所

第10章美洲3D列印藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區3D列印醫藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲3D列印藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • CurifyLabs 推出個人化醫療 3D 列印解決方案
    • Cellink 和 Carcinotech 合作透過 3D 生物列印轉變癌症藥物開發
    • Triastek 的 3D 列印藥物治療潰瘍性大腸炎獲得 FDA IND核准
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-431C35F6C179

[198 Pages Report] The 3D Printed Drugs Market size was estimated at USD 292.72 million in 2023 and expected to reach USD 331.22 million in 2024, at a CAGR 14.26% to reach USD 744.29 million by 2030.

3D printed drugs refer to the emerging use of 3D printing technology to create pharmaceutical products with improved drug delivery mechanisms. 3D printing of drugs enables personalization, precision, and cost-efficiency in drug manufacturing. The proliferation of 3D printed drugs is transforming the pharmaceutical industry, enabling the design of medications in any desired shape, size, dose, and delivery rate, delivering personalized healthcare for patients. Increased drug discovery and development activities and an inclination towards a personalized medicines approach are raising the need for advanced drug manufacturing techniques such as 3D printing of drugs. However, the high upfront cost of 3D printing technology may adversely impact the production of 3D printed drugs. Moreover, technological advancements in 3D printing technology are expected to enhance drug production efficiency, which is anticipated to expand its use for the development of drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 292.72 million
Estimated Year [2024] USD 331.22 million
Forecast Year [2030] USD 744.29 million
CAGR (%) 14.26%

Technology: Direct-write technology provides personalized and effective medication solutions

Direct-write technology in the context of 3D printed drugs involves using precise deposition methods to create pharmaceutical products with controlled structures and compositions. This approach allows for the customization of drug formulations, enabling personalized medicine and more effective drug delivery. Fused deposition modeling (FDM), a widely used 3D printing technology, has also found application in the pharmaceutical industry to develop 3D-printed drugs. Inkjet printing technology has found applications in the pharmaceutical industry for 3D printing drugs, offering a precise and controlled method for depositing pharmaceutical materials. Powder bed printing technology holds promise in the pharmaceutical industry for creating customized and controlled drug delivery systems. Using stereolithography technology in 3D printing drugs shows promise for creating custom, controlled-release pharmaceuticals with precise dosages.

Dose Form: Potential adoption of 3D printed drugs in the form of capsule

3D printing allows for creating personalized and patient-specific doses, potentially optimizing treatment plans. Capsules can be 3D printed with multiple compartments, each containing a different drug or dosage, facilitating combination therapies. 3D printing at the nanoscale allows for the fabrication of drug-loaded nanoparticles with controlled release properties, optimizing drug delivery. 3D printing can encapsulate active pharmaceutical ingredients within nanoparticles, protecting them from degradation and ensuring stability. Tablets produced through 3D printing can be customized to individual patient needs, allowing for personalized dosages and treatment plans. 3D printing enables the creation of tablets with complex geometries, such as porous structures or multilayered designs, influencing drug release kinetics.

Application: Proliferating use for manufacturing of neurology drugs

3D printed drugs revolutionize dental care by offering personalized solutions such as customized aligners, dentures, and crowns. Customized drug delivery systems enable precise medication release for conditions such as periodontal diseases. This technology enhances treatment efficacy while minimizing side effects. In dental implants, 3D printing facilitates the creation of drug-loaded scaffolds, promoting faster healing and reducing the risk of infections. In neurology, 3D printed drugs are crucial in tailoring treatments for neurological disorders. Patient-specific drug formulations enable precise dosing, enhancing therapeutic outcomes for conditions such as epilepsy and neurodegenerative diseases. 3D printing transforms orthopedic medicine by enabling the fabrication of patient-specific medications and implants. In orthopedic drug delivery, 3D printing allows for development of personalized dosage forms tailored to the patient's needs. Moreover, 3D printed implants with incorporated drugs enhance the healing process, providing controlled and localized drug release to address inflammation and promote bone regeneration.

End-User: Significant penetration of 3D printed drugs in clinics & hospitals

In clinics & hospitals, medical professionals are focusing on delivering personalized medications and prefer 3D printed drugs tailored to meet specific patient needs. These 3D printed drugs are preferred as they increase the effectiveness of treatments and reduce the risks and side effects commonly associated with traditional, mass-produced medications. Research laboratories heavily utilize 3D printed drugs due to their precision and accuracy. 3D printed drugs enable researchers to conduct concrete studies and rigorous research on drug interactions and medicinal effectiveness. Specialty clinics, such as those built around personalized medical treatments, increasingly leverage 3D printed drugs to cater to their unique patient needs. Personalized medication could enhance patient compliance and treatment efficiency since medication could be tailored to each patient's unique physiology. Clinics & hospitals, and special clinics widely adopt 3D printed drugs for enhanced patient treatment protocols, while research laboratories focus on the tangible benefits they provide for medical innovation and drug testing.

Regional Insights

The Americas have a significant landscape in the 3D-printed drugs market owing to progressive medical research and development, the robust pharmaceutical industry, and the presence of key 3D-printed drug manufacturers. Rising technological advancements and enhanced healthcare infrastructure further advance the market landscape in the region. Europe has observed a significant market for 3D printed drugs, driven by a rising geriatric population, initiatives towards personalized medicine, supportive governmental regulations, and funding activities from government and key manufacturers. In the Middle East & Africa, increasing investments in technological adoption and healthcare infrastructure enhancement contribute to market growth. The Asia-Pacific region is witnessing an emerging stage in the 3D printed drugs market and shows significant growth potential driven by factors such as rapid urbanization, innovations in healthcare technologies, increasing healthcare expenditures, and a rising elderly population requiring customized medication.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Printed Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Printed Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Direct-Write
    • Fused Deposition Modelling
    • Inkjet Printing
    • Powder Bed Printing
    • Stereolithography
    • Zip Dose
  • Dose Form
    • Capsule
    • Nanoparticles
    • Tablet
  • Application
    • Dental
    • Neurology
    • Orthopedic
  • End-User
    • Clinics & Hospitals
    • Research Laboratories
    • Speciality Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Printed Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Printed Drugs Market?

3. What are the technology trends and regulatory frameworks in the 3D Printed Drugs Market?

4. What is the market share of the leading vendors in the 3D Printed Drugs Market?

5. Which modes and strategic moves are suitable for entering the 3D Printed Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in demand for instantaneous soluble drugs
      • 5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
      • 5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant technological developments in 3D printing technique
      • 5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in manufacturing of 3D printed drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
    • 5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
    • 5.2.3. Application: Proliferating use for manufacturing of neurology drugs
    • 5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. 3D Printed Drugs Market, by Technology

  • 6.1. Introduction
  • 6.2. Direct-Write
  • 6.3. Fused Deposition Modelling
  • 6.4. Inkjet Printing
  • 6.5. Powder Bed Printing
  • 6.6. Stereolithography
  • 6.7. Zip Dose

7. 3D Printed Drugs Market, by Dose Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Nanoparticles
  • 7.4. Tablet

8. 3D Printed Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Dental
  • 8.3. Neurology
  • 8.4. Orthopedic

9. 3D Printed Drugs Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics & Hospitals
  • 9.3. Research Laboratories
  • 9.4. Speciality Clinics

10. Americas 3D Printed Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific 3D Printed Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa 3D Printed Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
    • 13.3.2. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
    • 13.3.3. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. 3D PRINTED DRUGS MARKET DYNAMICS
  • FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 359. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)
  • TABLE 360. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2023 (USD MILLION)

TABLE 3